| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $895,065 | 17 | 100 |
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney …
Over the last 12 months, insiders at Gyre Therapeutics, Inc. have bought $0 and sold $895,065 worth of Gyre Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Gyre Therapeutics, Inc. have bought $0 and sold $1.14M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2026-06-18 | Sale | Ye Weiguo | Chief Operating Officer | 3,000 0.0031% | $6.35 | $19,050 | +5.44% | |
| 2026-06-11 | Sale | Ye Weiguo | Chief Operating Officer | 2,800 0.0029% | $6.17 | $17,276 | +8.09% | |
| 2026-06-10 | Sale | Ye Weiguo | Chief Operating Officer | 6,418 0.0069% | $6.21 | $39,856 | +9.92% | |
| 2026-06-10 | Sale | Ye Weiguo | Chief Operating Officer | 5,000 0.0054% | $6.24 | $31,200 | +9.92% | |
| 2026-06-09 | Sale | Ye Weiguo | Chief Operating Officer | 14,500 0.015% | $6.14 | $89,030 | +6.61% | |
| 2026-06-09 | Sale | Ye Weiguo | Chief Operating Officer | 3,000 0.0031% | $6.15 | $18,450 | +6.61% | |
| 2026-06-05 | Sale | Ye Weiguo | Chief Operating Officer | 15,401 0.0162% | $6.40 | $98,566 | +3.74% | |
| 2026-06-04 | Sale | Ye Weiguo | Chief Operating Officer | 19,575 0.02% | $6.13 | $119,995 | +5.33% | |
| 2026-05-26 | Sale | Ye Weiguo | Chief Operating Officer | 4,000 0.0042% | $6.10 | $24,400 | +8.92% | |
| 2026-05-22 | Sale | Ye Weiguo | Chief Operating Officer | 3,500 0.0036% | $6.08 | $21,280 | +6.77% | |
| 2026-05-21 | Sale | Ye Weiguo | Chief Operating Officer | 12,820 0.0132% | $6.15 | $78,843 | +4.53% | |
| 2026-05-19 | Sale | Ye Weiguo | Chief Operating Officer | 9,120 0.0096% | $6.37 | $58,094 | +2.96% | |
| 2026-05-18 | Sale | Ye Weiguo | Chief Operating Officer | 200 0.0002% | $6.62 | $1,324 | 0.00% | |
| 2026-05-15 | Sale | Ye Weiguo | Chief Operating Officer | 13,100 0.0137% | $6.65 | $87,115 | -1.68% | |
| 2026-05-14 | Sale | Ye Weiguo | Chief Operating Officer | 15,580 0.0159% | $6.91 | $107,658 | -8.00% | |
| 2026-05-06 | Sale | Luo Ying | Chief Executive Officer | 10,136 0.0105% | $8.04 | $81,493 | -19.53% | |
| 2026-05-05 | Sale | Luo Ying | Chief Executive Officer | 179 0.0002% | $8.01 | $1,434 | -16.77% | |
| 2025-05-28 | Sale | Ma Songjiang | President | 558 0.0007% | $10.07 | $5,619 | -18.54% | |
| 2025-05-27 | Sale | Ma Songjiang | President | 2,000 0.0023% | $10.28 | $20,560 | -24.46% | |
| 2025-05-23 | Sale | Ma Songjiang | President | 182 0.0002% | $10.24 | $1,864 | -11.41% |
| Increased Positions | 25 | +64.1% | 346,577 | +11.2% |
| Decreased Positions | 14 | -35.9% | 97,554 | -3.15% |
| New Positions | 2 | New | 10,909 | New |
| Sold Out Positions | 6 | Sold Out | 63,849 | Sold Out |
| Total Postitions | 50 | +28.21% | 3M | +8.04% |
| Vanguard Group Inc | $7,835.00 | 1.26% | 1.15M | +850 | +0.07% | 2025-09-30 |
| Blackrock, Inc. | $4,490.00 | 0.73% | 659,397 | -183,212 | -21.74% | 2025-09-30 |
| Geode Capital Management, Llc | $2,551.00 | 0.41% | 374,620 | -27,089 | -6.74% | 2025-09-30 |
| State Street Corp | $1,245.00 | 0.2% | 182,753 | +4,985 | +2.8% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $1,143.00 | 0.18% | 167,866 | -64,433 | -27.74% | 2025-09-30 |
| Charles Schwab Investment Management Inc | $840.00 | 0.14% | 123,386 | -6,034 | -4.66% | 2025-09-30 |
| Northern Trust Corp | $792.00 | 0.13% | 116,342 | -26,987 | -18.83% | 2025-09-30 |
| State Of Wisconsin Investment Board | $266.00 | 0.04% | 39,000 | +1,330 | +3.53% | 2025-09-30 |
| Millennium Management Llc | $243.00 | 0.04% | 35,751 | +35,751 | New | 2025-09-30 |
| Bank Of New York Mellon Corp | $166.00 | 0.03% | 24,398 | +409 | +1.71% | 2025-09-30 |